CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.66 Billion 1.63 Billion 2.27 Billion 3.76 Billion 2.95 Billion 1.63 Billion
Total Current Assets 1.32 Billion 1.24 Billion 1.95 Billion 3.57 Billion 2.88 Billion 1.6 Billion
Cash And Short Term Investments 1.02 Billion 1.04 Billion 1.72 Billion 3.39 Billion 2.74 Billion 1.55 Billion
Cash and Cash Equivalents 996.67 Million 558.68 Million 742.72 Million 3.02 Billion 1.12 Billion 701.33 Million
Short Term Investments 30 Million 483.4 Million 983.61 Million 368.99 Million 1.61 Billion 856.62 Million
Net Receivables 172.43 Million 77.13 Million 117.59 Million - - -
Inventory 108.82 Million 22.18 Million 61.36 Million - - -
Other Current Assets - - 122.89 Million 10.84 Million 12.56 Million 46.98 Million
Total Non-Current Assets 332.21 Million 391.51 Million 313.8 Million 190.44 Million 63.8 Million 27.17 Million
Net PPE 153.36 Million 206.56 Million 187.92 Million 101.95 Million 22.22 Million 14.53 Million
Good Will And Intangible Assets 173.04 Million 159.69 Million 70.53 Million 6.5 Million 1.3 Million 897 Thousand
Good Will - - - - - -
Intangible Assets 173.04 Million 159.69 Million 70.53 Million 6.5 Million 1.3 Million 897 Thousand
Long-Term Investments -26.45 Million -479.92 Million -980.42 Million - - -
Tax Assets - 479.92 Million - - - -
Other Non Current Assets 32.25 Million 25.24 Million 1.03 Billion 81.98 Million 40.27 Million 11.74 Million
Other Assets - - - - - -
Total Liabilities 1.2 Billion 1.18 Billion 1.06 Billion 808.29 Million 469.06 Million 1.11 Billion
Total Current Liabilities 850.33 Million 946.48 Million 932.94 Million 727.04 Million 457.96 Million 1.1 Billion
Account Payables 246.37 Million 290.41 Million 33.02 Million 28.03 Million 37.3 Million 4.55 Million
Tax Payables 17.66 Million 5.81 Million 24.28 Million 102.93 Million 97.58 Million 1.57 Million
Short Term Debt 139.31 Million 44.91 Million 43.94 Million 11.31 Million 4.34 Million -
Deferred Revenue - - - - - -
Other Current Liabilities 464.64 Million 611.15 Million 855.97 Million 687.7 Million 416.31 Million 1.1 Billion
Total Non Current Liabilities 354.83 Million 242.61 Million 131.49 Million 81.24 Million 11.09 Million 7.56 Million
Long-Term Debt 224.13 Million 241.37 Million 130.25 Million 72.54 Million - -
Deferred Revenue Non Current 61.96 Million 1.24 Million 1.24 Million 8.69 Million 11.09 Million 7.56 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 68.72 Million -218.98 Million -115.81 Million -54.34 Million - -
Other Liabilities - - - - - -
Total Equity 456.83 Million 449.32 Million 1.2 Billion 2.95 Billion 2.48 Billion 515.33 Million
Stock Holders Equity 456.83 Million 449.32 Million 1.2 Billion 2.95 Billion 2.48 Billion 515.33 Million
Common Stock 860 Thousand 802 Thousand 796 Thousand 787 Thousand 687 Thousand 29 Thousand
Retained Earnings -9.01 Billion -8.65 Billion -7.74 Billion -5.82 Billion -4.6 Billion -2.3 Billion
Accumulated other comprehensive income 455.97 Million 473.08 Million 491.43 Million 459.09 Million 438.43 Million -5.8 Million
Common Stock Equity 456.83 Million 449.32 Million 1.2 Billion 2.95 Billion 2.48 Billion 515.33 Million
Capital Lease Obligation 44.46 Million 58.73 Million 27.68 Million 26.85 Million 4.34 Million -
Total Investments 3.54 Million 3.48 Million 3.18 Million 368.99 Million 1.61 Billion 856.62 Million
Total Debt 363.44 Million 286.29 Million 174.19 Million 83.85 Million 4.34 Million -
Net Debt -633.22 Million -272.39 Million -568.52 Million -2.94 Billion -1.12 Billion -701.33 Million

Balance Sheet Charts